Bone health in breast cancer patients: A comprehensive statement by CECOG/SAKK Intergroup

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064165%3A_____%2F14%3A10286284" target="_blank" >RIV/00064165:_____/14:10286284 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.breast.2014.05.023" target="_blank" >http://dx.doi.org/10.1016/j.breast.2014.05.023</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.breast.2014.05.023" target="_blank" >10.1016/j.breast.2014.05.023</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Bone health in breast cancer patients: A comprehensive statement by CECOG/SAKK Intergroup

Popis výsledku v původním jazyce

Bone is the most common site of distant metastases in breast cancer that can cause severe and debilitating skeletal related events (SRE) including hypercalcemia of malignancy, pathologic fracture, spinal cord compression and the need for palliative radiation therapy or surgery to the bone. SRE are associated with substantial pain and morbidity leading to frequent hospitalization, impaired quality of life and poor prognosis. The past 25 years of research on the pathophysiology of bone metastases led to the development of highly effective treatment options to delay or prevent osseous metastases and SRE. Management of bone metastases has become an integral part of cancer treatment requiring expertise of multidisciplinary teams of medical and radiation oncologists, surgeons and radiologists in order to find an optimal treatment for each individual patient.

Název v anglickém jazyce

Bone health in breast cancer patients: A comprehensive statement by CECOG/SAKK Intergroup

Popis výsledku anglicky

Bone is the most common site of distant metastases in breast cancer that can cause severe and debilitating skeletal related events (SRE) including hypercalcemia of malignancy, pathologic fracture, spinal cord compression and the need for palliative radiation therapy or surgery to the bone. SRE are associated with substantial pain and morbidity leading to frequent hospitalization, impaired quality of life and poor prognosis. The past 25 years of research on the pathophysiology of bone metastases led to the development of highly effective treatment options to delay or prevent osseous metastases and SRE. Management of bone metastases has become an integral part of cancer treatment requiring expertise of multidisciplinary teams of medical and radiation oncologists, surgeons and radiologists in order to find an optimal treatment for each individual patient.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FD - Onkologie a hematologie

OECD FORD obor

—

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Breast

ISSN

0960-9776

e-ISSN

—

Svazek periodika

23

Číslo periodika v rámci svazku

5

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

15

Strana od-do

511-525

Kód UT WoS článku

000343408300003

EID výsledku v databázi Scopus

—